Cultivation service of adipose-derived mesenchymal stem cells used in the clinical trials at the Department of Advanced Medical Initiatives, Kyushu University for evaluating the safety and effectiveness of adipose-derived mesenchymal stem cells against hepatic cirrhosis has started since March 2016.


Posted in: 未分類.
Last Modified: July 14th, 2017

Leave a reply

required